BioStem Technologies joins Terminal1 investor relations platform
BSEM•BioStem Technologies adopts Terminal1 platform
- BioStem Technologies (BSEM) joined Terminal1’s platform to consolidate investor relations functions into a single system.
- Terminal1 tools will support shareholder intelligence, investor communications, IR website management, analytics, and integrated investor data.
- The partnership aims to improve visibility into ownership trends and investor engagement across BioStem’s investor ecosystem.
Related News
FMC updates financial calendar with third-quarter earnings release, webcast call
FMC•
CMS Announces New Preliminary Medicare Payment Rates For Laboratory Services, Saving Taxpayers An Estimated $1 Billion Annually
XLV•
